Venous thromboembolism, age and hospitalisation: A potentially deadly combination

Thrombosis and Haemostasis

Volumn 104, Issue 4, 2010, Pages 655-656

  Dentali, Francesco ^a   Crowther, Mark ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGE; BLEEDING; DEEP VEIN THROMBOSIS; EDITORIAL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG EMBOLISM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; VENOUS THROMBOEMBOLISM;

AGED; CLINICAL TRIALS AS TOPIC; HOSPITALIZATION; HUMANS; INCIDENCE; RISK FACTORS; RISK MANAGEMENT; SURVIVAL RATE; THROMBOLYTIC THERAPY; VENOUS THROMBOEMBOLISM;

EID: 77958115354     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0527     Document Type: Editorial

References (19)

1. Spyropoulos AC, Hussein M, Lin J, et al. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost 2009; 102: 951-957.
2. Fanikos J, Piazza G, Zayaruzny M, et al. Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost 2009; 102: 688-693.
3. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
4. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S (Pubitemid 351894916)
5. Kalka C, Spirk D, Siebenrock KA, et al. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL). Thromb Haemost 2009; 102: 56-61.
6. Goldhaber SZ. Venous thromboembolism prophylaxis: quality, location (hospital vs. home), and duration. Thromb Haemost 2009; 102: 1-2.
7. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-288. (Pubitemid 351650614)
8. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9-15. (Pubitemid 32709732)
9. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II Investigators. Duration ofprophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346: 975-980.
10. Squizzato A, Ageno W. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines. Thromb Haemost 2009; 101: 31-35.
11. Ambrosetti M, Salerno M, Zambelli M, et al. Deep vein thrombosis among patients entering cardiac rehabilitation after coronary artery bypass surgery. Chest 2004; 125: 191-196 (Pubitemid 38114583)
12. Heit JA, O'Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162: 1245-1248. (Pubitemid 34595030)
13. Sellier E, Labarere J, Sevestre MA, et al.; Association pour la Promotion de l'Angiologie Hospitalière. Risk factors for deep vein thrombosis in older patients: a multicenter study with systematic compression ultrasonography in postacute care facilities in France. J Am Geriatr Soc 2008; 56: 224-230.
14. Spencer FA, Gore JM, Reed G, et al. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost 2009; 101: 878-885.
15. Vasco B, Villalba JC, Lopez-Jimenez L, et al.; RIETE Investigators. Venous thromboembolism in nonagenarians. Findings from the RIETE Registry. Thromb Haemost 2009; 101: 1112-1118.
16. Bosson JL, Labarere J, Sevestre MA, et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med 2003; 163: 2613-2618. (Pubitemid 37464419)
17. Labarère J, Sevestre MA, Belmin J, et al; Association pour la Promotion de l'Angiologie Hospitalière. Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies. Drugs Aging 2009; 26: 263-271.
18. Bosson JL, Labarere J, Barrellier MT, et al; Association for the Promotion of Hospital Angiology. Practice guidelines for the prevention of venous thromboembolism in elderly patients hospitalized in subacute care and rehabilitation facilities. J Mal Vasc 2003; 28: 209-218. (Pubitemid 37328506)
19. Scannapieco G, Ageno W, Airoldi A et al. for the TERSICORE Study Group. Incidence and Predictors of Venous Thromboembolism in Post-Acute Care Patients: A Prospective Cohort Study. Thromb Haemost 2010; 104: 734-740.